Nanomaterials

Index

• 1-100nm, 154
• 2-D materials, 61–62
• β-galactosidase, 228

A

• Acetaminophen (APAP), 142
• Activated carbon fibers, 223, 225
• Active pharmaceutical ingredients, 138–139
• Acyclovir, 139
• Amoxicillin, 143–144
• Ampicillin, 143–144
• Anithistamines, 138
• Annular dark field-scanning TEM, 72
• Anode, 221, 226, 227
• Antibiotics, 138
• Anti-caking agents, 157
• Antiepileptics, 138
• Anti-ferromagnetic materials, 171–177
• Arc-discharge method, 17–18, 108–110
• Artificial neural networks, 145
• Atherosclerotic plaque, 186

B

• Band gap, 62
• Bar coding, 278
• Beta blockers, 138
• Biofilm, 225
• Biofuels, 217, 227
• Biohydrogen, 217–218
• Biological nanopores, 261
• Biophotolysis, 218–220
• Biosensors, 292–294

C

• Cancer markers, 277
  • cancer, 187
• Carbon filament growth,
  • base growth model, 24–25
  • tip growth model, 24
• Carbon foot print, 217
• Carbon nanotubes (CNTs), 198, 200–203, 205–207, 213, 241–242, 244–245, 248, 250
  • applications, 28–32
  • characterization of, 32–47, 123–126
  • classification of, 13–15, 107
  • composite of, 47–49
  • crystal structure, 15–17
  • defects in, 120–123
  • deformations in, 118–120
  • electronic properties, 27
  • history of, 5–7
  • mechanical properties, 28
  • mechanism of growth, 23–26
  • molecular, 4–5
  • precursors, 112–114
  • purification process, 22–23
  • structure, 13
  • synthesis methods, 17–21, 49–50, 107–112
  • types, 106–107
• Catalyst, type of, 114–115
• Cathode, 221, 227
• Cell inflammation, 189
• Cell migration, 186
• Cellulases, 227
• Chemical vapor deposition, 20–21, 70, 110–112
  • parameters of, 112–118
• Chirality, 14
• Chroium di-oxide, ...